Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upregulating Klotho

Lijuan Cheng1, Lei Zhang1, Jun Yang2

  • 1Department of Nephrology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.

Insights

Peroxisome proliferator-activated receptor (PPAR) γ activation inhibits vascular smooth muscle cell calcification by increasing Klotho expression. This pathway is crucial for managing mineral metabolism in chronic kidney disease patients.

Area of Science:

  • Nephrology
  • Cardiovascular Biology
  • Molecular Biology

Background:

  • Cardiovascular diseases are prevalent in chronic kidney disease (CKD) patients.
  • Vascular smooth muscle cell (VSMC) calcification, driven by mineral imbalance, is a key complication.
  • Klotho, an aging suppressor, is linked to vascular calcification.

Purpose of the Study:

  • To investigate if peroxisome proliferator-activated receptor (PPAR) γ regulates VSMC calcification via Klotho modulation.
  • To explore the therapeutic potential of PPARγ agonists in managing VSMC calcification.

Main Methods:

  • Induction of VSMC calcification using inorganic phosphate (Pi).
  • Assessment of PPARγ and Klotho expression levels.
  • Treatment with PPARγ agonists and Klotho knockdown using RNA interference.
  • Measurement of Pi transporter 1/2 expression and Pi influx.

Main Results:

  • PPARγ expression decreased during Pi-induced VSMC calcification.
  • PPARγ agonists inhibited calcification and increased Klotho expression in a PPARγ-dependent manner.
  • Klotho knockdown abolished the inhibitory effect of PPARγ activation on VSMC calcification.
  • Both Klotho and PPARγ activation reduced Pi transporter expression and Pi influx.

Conclusions:

  • PPARγ activation inhibits VSMC calcification by upregulating Klotho expression.
  • This study establishes a novel mechanism linking PPARγ, Klotho, and mineral metabolism in vascular calcification.
  • Targeting the PPARγ-Klotho axis may offer a therapeutic strategy for cardiovascular complications in CKD.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
4.1K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
6.3K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.5K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
5.1K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.8K